Dysphagia, trismus and speech impairment following radiation-based treatment for advanced stage oropharyngeal carcinoma: a one-year prospective evaluation

Rebecca T. Karsten, Najiba Chargi, Lisette van der Molen, Rob J.J.H. van Son, Remco de Bree, Abrahim Al-Mamgani, Jan P. de Boer, Frans J.M. Hilgers, Michiel W.M. van den Brekel, Ludi E. Smeele, Martijn M. Stuiver

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Objective: The objective was to assess swallowing, mouth opening and speech function during the first year after radiation-based treatment (RT(+)) after introduction of a dedicated preventive rehabilitation program for stage III–IV oropharyngeal carcinoma (OPC). Methods: Swallowing, mouth opening and speech function were collected before and at six- and twelve-month follow-up after RT(+) for OPC as part of ongoing prospective assessments by speech-language pathologists. Results: Objective and patient-perceived function deteriorated until 6 months and improved until 12 months after treatment, but did not return to baseline levels with 25%, 20% and 58% of the patients with objective dysphagia, trismus and speech problems, respectively. Feeding tube dependency and pneumonia prevalence was low. Conclusion: Despite successful implementation, a substantial proportion of patients still experience functional limitations after RT(+) for OPC, suggesting room for improvement of the current rehabilitation program. Pretreatment sarcopenia seems associated with worse functional outcomes and might be a relevant new target for rehabilitation strategies.

Original languageEnglish
Pages (from-to)1003-1027
Number of pages25
JournalEuropean Archives of Oto-Rhino-Laryngology
Volume279
Issue number2
Early online date27 May 2021
DOIs
Publication statusPublished - Feb 2022

Funding

We would like to acknowledge the speech-language pathologists at our institute Anne Kornman, Merel Latenstein, Klaske van Sluis, and Nadya van Gent for the data collection. Jasmine de Jong is acknowledged for her contribution to building the database. The Netherlands Cancer Institute receives a research grant from Atos Medical Sweden, which contributes to the existing infrastructure for health-related, quality-of-life research in the Department of Head and Neck Oncology and Surgery.

FundersFunder number
ATOS Medical Sweden
Netherlands Cancer Institute
Nadya van Gent
Not added104519

    Fingerprint

    Dive into the research topics of 'Dysphagia, trismus and speech impairment following radiation-based treatment for advanced stage oropharyngeal carcinoma: a one-year prospective evaluation'. Together they form a unique fingerprint.

    Cite this